Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Price Control

    Tag: price control

    You Searched For "Price Control"
    NPPA caps trade margins to 30 percent for 42 cancer drugs

    NPPA caps trade margins to 30 percent for 42 cancer drugs

    Meghna A Singhania28 Feb 2019 9:20 AM IST
    As per data available with NPPA, the MRP for 105 brands will be reduced up to 85 per cent entailing minimum saving of Rs 105 crore to consumers, it...
    Relief to Foreign Drugmakers: No price cap on innovative drugs for first five years

    Relief to Foreign Drugmakers: No price cap on innovative drugs for first five years

    Farhat Nasim5 Jan 2019 10:44 AM IST
    New Delhi: Through a recent Gazette notice the Central Government has made amendments to the Drugs Prices Control Orders (DPCO),2013 which aim to...
    Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer

    Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer

    Ruby Khatun Khatun3 Sept 2018 10:30 AM IST
    Mumbai: Pharma major Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new...
    NPPA notifies prices of 65 essential formulations

    NPPA notifies prices of 65 essential formulations

    Ruby Khatun Khatun19 Dec 2017 5:11 PM IST
    New Delhi: National drug pricing regulator NPPA said it has notified prices of 65 essential formulations, including those used for the treatment of...
    MTaI  response to knee implant price control

    MTaI response to knee implant price control

    Ruby Khatun Khatun16 Dec 2017 10:30 AM IST
    New Delhi: Patient access is an indisputable goal. The ways governments try to reach it are many. The easier methods are usually unfruitful. A deeper...
    Now non-essential drugs fall under price control

    Now non-essential drugs fall under price control

    Ruby Khatun Khatun23 Oct 2017 5:45 PM IST
    New Delhi: The government's push for a change in the method of price calculation methodology for new drugs can lead to non-essential drugs coming...
    MTaI urges govt to look at sub-categorization of devices

    MTaI urges govt to look at sub-categorization of devices

    Ruby Khatun Khatun21 Sept 2017 11:01 AM IST
    New Delhi: The medical technology industry has reached out to the government to look at sub-sectoring and sub-categorization of medical devices on the...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok